Heme Onc Trial Files
TrialFilesFree monthly newsletter that summarizes the most significant, practice-changing heme-onc randomized controlled trials, straight to your inbox.
| Platform |  | Pricing | Only free issues | Publishes | Monthly |
|---|---|---|---|---|---|
| Issues | 13 | Founded | a year ago | Last Issue | 4 days ago |
| Active | |||||
Read this Newsletter
hemeonctrialfiles.substack.comLatest Issues
Heme Onc Trial Files Throwback Thursday: RVD + ASCT + Lenalidomide, Carfilzomib-Dex +/- Isatuximab, and Lenalidomide Post ASCT in MM
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma
Richardson PG et al. NEJM (June 2022)
Bottom Line: This phase 3 randomized trial (DETERMINATION) enrolled 722 adults aged 18–65 years with newly diagnosed...
Heme Onc Trial Files: Asciminib in CML, Orca-T vs. Allo-HSCT, and Fixed-Duration vs. Continuous Therapy in CLL
Asciminib demonstrates superior efficacy and safety in newly diagnosed chronic myeloid leukemia (ASC4FIRST)
Cortes JE et al. Blood (March 2026)
Bottom Line: This phase 3 randomized trial (ASC4FIRST) evaluated asciminib versus investiga...
Heme Onc Trial Files Throwback Thursday: DA-EPOCH-R vs R-CHOP, DA-EPOCH-R in MYC-Rearranged Disease, and De-escalation in Favorable-Risk DLBCL
Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303
Bartlett NL et al. J Clin Oncol (April 2019)
Bottom Line: This...
Heme Onc Trial Files: Epcoritamab-R² in Follicular Lymphoma, Venetoclax in t(11;14) Myeloma, and CAR-T Durability in LBCL
Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1)
Falchi L et al. Lancet (January 2026)
Bottom Line: This multicountry, open-label, phase 3 trial ev...
Heme Onc Trial Files Throwback Thursday: Brentuximab Vedotin+AVD, PET-Guided Therapy, and Nivolumab+AVD in Advanced Hodgkin’s Lymphoma
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin’s Lymphoma
Connors JM et al. NEJM (January 2018)
Bottom Line: This open-label, multicenter, randomized phase 3 trial involved 1334 patients with previously untreated st...
Key Facts
Audience Metrics
Subscribers, engagement, traffic and sponsorship for Heme Onc Trial Files.
| Subscribers | Engagement | 60 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Explore More
Authors
The writers behind this newsletter.
Free biweekly newsletter for trainees and staff on General Internal Medicine at Sinai Health that summarizes the most significant, practice-changing randomized controlled trials, straight to your inbox.
Frequently Asked Questions
How can I access the email archive for Heme Onc Trial Files?
You can find recent issues that have been published by Heme Onc Trial Files on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does Heme Onc Trial Files have?
To see how many people subscribe to Heme Onc Trial Files, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in Heme Onc Trial Files?
Newsletter advertising can be extremely effective when it's done right. Before you pitch Heme Onc Trial Files as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like Heme Onc Trial Files?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Heme Onc Trial Files using the contact information provided and ask for a copy of their media kit.
How can I find newsletters related to Heme Onc Trial Files?
Scroll up to where it says Related Newsletters to see other publications like Heme Onc Trial Files. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact Heme Onc Trial Files?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.